Cheapest GLP 1 without insurance: what each drug actually costs in 2026

So the cheapest brand name GLP 1 you can get without insurance right now is Wegovy pill at 1.5 mg or 4 mg, which costs $149 per month through Novo Nordisk's NovoCare Pharmacy. That's real, verified number straight from manufacturer. No coupon stacking or anything.

But that $149 comes with catches you need to know about before you get excited. Not every dose is $149. Not every drug has a direct to consumer program this low. And total cost of being on a GLP 1 is more than just drug. Let's go through every option so you can see actual numbers side by side.

What does each GLP 1 drug cost without insurance right now?

Wegovy (semaglutide injection and pill):

• Wegovy pill 1.5 mg and 4 mg: $149 per month through NovoCare Pharmacy. The 4 mg price holds until August 31, 2026, then goes up to $199.
  
  

• Wegovy injection starter doses (0.25 mg and 0.5 mg): $199 per month for new patients, but only for first two fills through June 30, 2026. After that it jumps to $349 per month.
  
  

• Wegovy injection at maintenance doses (1 mg, 1.7 mg, 2.4 mg): $349 per month.
  
  

• Wegovy HD 7.2 mg: $399 per month.

So $149 is real, but it's only available at two specific pill doses. Once you're on injection at a maintenance dose, you're at $349 per month minimum.

Zepbound (tirzepatide injection):

• Zepbound vials through LillyDirect: $299 for 2.5 mg (starting dose), $399 for 5 mg, and $449 for all other doses.
  
  

• These are multi dose vials, not standard prefilled pens. You draw up your own dose with a syringe. That's how Eli Lilly gets price lower. The pens still cost over $1,000 at retail.

• LillyDirect also has virtual doctors on platform who can write prescription for you, so you don't need to bring your own if you're starting from scratch.

Ozempic (semaglutide injection, prescribed for diabetes):

• Ozempic through NovoCare Pharmacy: $199 for first two fills (new patients, through June 30, 2026). After that, $349 per month for 0.25 mg, 0.5 mg, and 1 mg. The 2 mg dose stays at $499.
  
  

• Ozempic is FDA approved for type 2 diabetes, not weight loss. If your doctor prescribes it off label for weight loss, self pay program still works, but you need a valid prescription.

Foundayo (orforglipron, oral GLP 1):

• Available through select programs starting at $149 per month. This is a daily pill, not an injection. It's newest GLP 1 on the market.

Saxenda (liraglutide injection):

• Self pay pricing is around $1,400 per month with very few manufacturer discount routes. This is oldest weight loss GLP 1 still on market, and it doesn't have aggressive self pay programs newer drugs do. If you're comparing Saxenda vs Zepbound, cost gap alone is a reason most doctors start with newer options.

Trulicity (dulaglutide injection):

• Available at $389 per month through Eli Lilly's programs. Approved for type 2 diabetes only.

What about compounded GLP 1 drugs?

Compounded semaglutide used to be a budget option. In 2024, you could find it at $99 to $150 per month through hundreds of telehealth platforms using licensed 503A compounding pharmacies.

That's gotten harder in 2026. The FDA ended semaglutide shortage declaration in February 2025, which narrowed the legal basis for 503A pharmacies to compound copies of drug. Compounded semaglutide is still available through some pharmacies that can justify individualized prescriptions, but number of sources has dropped and prices have crept up.

People who are actually paying out of pocket right now report a wide range depending on platform. Some telehealth services like Goby Meds offer a 3 month starter kit for around $299 with no separate membership fee. Others charge a lower monthly drug price but tack on a quarterly or monthly membership. CallonDoc, for example, charges a $60 quarterly membership that includes prescribing, with medication cost on top. Brello Health runs around $399 for three months of any semaglutide dose, which breaks down to about $133 per month. Pomegranate Health charges $229 for two months at doses up to 1 mg, and $269 for two months at higher doses.

The numbers bounce around, but realistic compounded semaglutide pricing in April 2026 sits between $115 and $269 per month depending on your dose and whether platform bundles consultation into price or charges separately.

Compounded tirzepatide is even harder to find. The FDA declared tirzepatide no longer in shortage in late 2025, and most compounders stopped producing it. The few that remain charge $199 to $400 per month.

If you go compounded route, there are two things that matter more than price. First, pharmacy should be a licensed 503A or 503B facility with current state licensing. Second, they should have independent third party testing for potency and sterility. Ask for certificate of analysis. If they can't produce one, find a different pharmacy.

What costs do people forget to add in?

The drug price is number everyone focuses on, but it's not whole bill. When you're paying out of pocket, you're also covering costs that insurance would normally absorb.

The prescribing visit is usually $100 to $250 through a telehealth platform, or $150 to $350 in person. Some telehealth companies bundle this into monthly price. Others charge it separately. A platform might advertise "$149 per month" but then charge a $25 monthly membership plus a $60 quarterly consultation fee on top. Read full breakdown before you sign up. The advertised price and price you actually pay each month are often two different numbers.

Blood work is other one. Most prescribers want at least a baseline metabolic panel and an A1C before they prescribe. At a cash pay lab, that's $50 to $200 depending on where you go. Follow up labs every three to six months add up over a year. Some telehealth platforms skip labs entirely, which keeps costs down but also means less medical oversight. That's a tradeoff you should make with your eyes open.

Follow up appointments are every one to three months depending on your prescriber. Some telehealth platforms include unlimited check ins. Others charge $50 to $100 per visit after first one.

When you add drug, prescribing visit, labs, and follow ups together, real monthly cost of cheapest brand name GLP 1 without insurance is closer to $200 to $450 depending on which drug and which dose you're on. That's still a fraction of $1,000+ list price. But it's more than $149 headline number suggests.

What are people actually doing to pay less?

Beyond official programs, people share a lot of real world strategies in online communities that are worth knowing about.

If you're near southern U.S. border, some people make day trips to Mexican pharmacies where brand name GLP 1 drugs sell for a fraction of U.S. price. This is legal for personal use in small quantities, but quality and authenticity of what you're buying depends entirely on pharmacy, and there's no prescriber following your dosing.

If you still have insurance today but know you're losing it soon, filling as many refills as possible while covered is something people do to build a buffer. GLP 1 drugs stored properly in fridge last through their expiration date.

If your insurance denied coverage for weight loss, check whether your doctor can prescribe it under a different covered indication. Some plans cover GLP 1s for type 2 diabetes, cardiovascular risk reduction, or obstructive sleep apnea even when they won't cover it for obesity alone. Your doctor can review whether you qualify under one of those categories.

Some of these approaches carry more risk than others. The manufacturer programs and patient assistance routes are safest and most straightforward. But people who are priced out of those options do find workarounds, and it's better to know what they are than to assume list price is only number that exists.

Is there a way to get a GLP 1 for free?

Yes, if your income qualifies. Both Novo Nordisk and Eli Lilly run patient assistance programs that provide free medication to people who meet income thresholds and don't have insurance coverage.

Novo Nordisk's program (through NovoCare) covers Wegovy and Ozempic. Eli Lilly's program (Lilly Cares) covers Mounjaro and Zepbound. The application process takes a few weeks, requires income documentation, and your doctor needs to submit a form on your behalf. But if you qualify, drug itself costs $0.

These programs don't cover doctor visits or labs. You still pay for those out of pocket. But drug is usually the biggest line item, so removing it makes rest manageable.

What if you're switching drugs to save money?

If you're already on a GLP 1 and cost is getting hard to sustain, switching from Wegovy to Zepbound or vice versa is something people do specifically to take advantage of a different manufacturer's pricing program.

That's a conversation for your doctor. The drugs work through slightly different receptor pathways, and switching isn't a one to one dose swap. But cost difference between two drugs at their self pay prices can be $100 to $200 per month at same treatment stage, which adds up to over $1,000 a year. If clinical outcomes are comparable for your situation, price difference is a legitimate reason to switch.

So what's the actual cheapest path?

If you're starting fresh with no insurance, and you want a brand name FDA approved drug, Wegovy pill at $149 per month through NovoCare Pharmacy is lowest verified price right now. Add roughly $50 to $100 per month for medical costs around it, and you're looking at about $200 to $250 total per month at the lowest dose.

If you're comfortable with compounded medication and you find a properly licensed pharmacy, compounded semaglutide can still come in at $129 to $150 per month, plus telehealth platform fee.

If your income qualifies for a patient assistance program, you can get drug itself for $0 and just pay for visits and labs.

There's no scenario where a GLP 1 costs nothing. But the gap between $1,349 list price and what you can actually pay today is widest it's ever been.